Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. AbbVie Inc.
  6. Summary
    ABBV   US00287Y1091

ABBVIE INC.

(ABBV)
  Report
Delayed Nyse  -  04:03 2022-12-07 pm EST
165.40 USD   +1.03%
12/07Global markets live: Glencore, Apple, Netflix, Tesla, Amazon...
MS
12/06Major Pharma Companies to Remain Defensive Through at least H1 2023 Amid M&As, New Products Focus, Morgan Stanley Says
MT
12/06AbbVie Signs Strategic Collaboration Deal With HotSpot Therapeutics to Treat Autoimmune Diseases
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Nyse
12/01/2022 12/02/2022 12/05/2022 12/06/2022 12/07/2022 Date
161.63(c) 163.66(c) 163.94(c) 163.72(c) 165.4(c) Last
5 827 897 4 305 089 4 859 547 5 480 495 4 637 777 Volume
+0.28% +1.26% +0.17% -0.13% +1.03% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 58 331 M - -
Net income 2022 14 600 M - -
Net Debt 2022 54 634 M - -
P/E ratio 2022 19,7x
Yield 2022 3,43%
Sales 2023 54 376 M - -
Net income 2023 12 430 M - -
Net Debt 2023 45 577 M - -
P/E ratio 2023 22,6x
Yield 2023 3,59%
Capitalization 292 B 292 B -
EV / Sales 2022 5,95x
EV / Sales 2023 6,22x
Nbr of Employees 50 000
Free-Float 97,4%
More Financials
Company
AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, CrohnÔ'Ts disease, thyroid disease, ParkinsonÔ'Ts disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (77.4%), Canada (2.5%),... 
Sector
Pharmaceuticals
Calendar
01/12Ex-dividend day for
More about the company
Ratings of AbbVie Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about ABBVIE INC.
12/07Global markets live: Glencore, Apple, Netflix, Tesla, Amazon...
MS
12/06Major Pharma Companies to Remain Defensive Through at least H1 2023 Amid M&As, New Prod..
MT
12/06AbbVie Signs Strategic Collaboration Deal With HotSpot Therapeutics to Treat Autoimmune..
MT
12/06AbbVie Launches Strategic Collaboration with HotSpot Therapeutics to Further Expand Imm..
PR
12/06Morgan Stanley Lifts Price Target on AbbVie to $182 From $178, Maintains Overweight Rat..
MT
12/06AbbVie to Showcase Migraine Portfolio and Pipeline During the 16th European Headache Fe..
PR
12/02Merck could keep its patent edge by shifting Keytruda cancer drug to a simple shot
RE
12/01Transcript : AbbVie Inc. Presents at Piper Sandler 34th Annual Healthcare Con..
CI
12/01AbbVie Announces Provincial Reimbursement for RINVOQ« (upadacitinib) for the Treatment ..
AQ
12/01Abbvie Inc. Announces Provincial Reimbursement for RINVOQ (Upadacitinib) for the Treatm..
CI
11/29Transcript : AbbVie Inc. Presents at 5th Annual Evercore ISI HealthCONx Confe..
CI
11/29Rare success for Alzheimer's research unlocks hope for future therapies
RE
11/29Abbvie Inc. : Change in Directors or Principal Officers (form 8-K)
AQ
11/28MarketScreener's World Press Review : November 28, 2..
MS
11/28North American Morning Briefing: Covid Protests in China Spread, Hit Market Se..
DJ
More news
News in other languages on ABBVIE INC.
03:46aOpiniones de los analistas del día: Generali, STMicro..
12/07EN DIRECTO DESDE LOS MERCADOS: Sabadell, Iberdrola, Glenco..
12/07Bolsa de Madrid: China condenada a reaccionar
12/07La Chine condamnée à réagir
12/07En Direct des Marchés : Sanofi, Engie, Airbus, EuroAPI, Tesla, App..
More news
Analyst Recommendations on ABBVIE INC.
More recommendations
ETFs positioned on ABBVIE INC.ETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
First Trust Morningstar Dividend Leaders In...8.05%-2.03%United_States
Nomura NEXT FUNDS International Equity MSCI...6.85%0.45%-World
IShares U.S. High Dividend Equity Index ETF...6.83%-1.47%United_States
IShares Core High Dividend ETF - USD6.64%-1.42%United_States
Invesco Dynamic Pharmaceuticals ETF - USD6.02%1.90%United_States
More ETFs positioned on ABBVIE INC.
Chart ABBVIE INC.
Duration : Period :
AbbVie Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABBVIE INC.
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Last Close Price 165,40 $
Average target price 158,22 $
Spread / Average Target -4,34%
EPS Revisions
Managers and Directors
Richard A. Gonzalez Chairman & Chief Executive Officer
Robert A. Michael Vice Chairman & President
Scott T. Reents Chief Financial Officer & Senior Vice President
Thomas J. Hudson VP, Head-Oncology Discovery & Early Development
Azita Saleki-Gerhardt Executive Vice President-Operations
Sector and Competitors
1st jan.Capi. (M$)
ABBVIE INC.22.16%292 407
JOHNSON & JOHNSON2.94%463 208
ELI LILLY AND COMPANY33.42%353 438
NOVO NORDISK A/S20.94%283 266
PFIZER, INC.-15.82%282 013
MERCK & CO., INC.43.65%279 122